D-0197-2025 Class III Ongoing
FDA drug recall D-0197-2025 was initiated by Akron Pharma, Inc. on Dec 12, 2024 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID. The recall status is ongoing. Affected quantity: 7198 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2025
- Initiation Date
- Dec 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7198 bottles
Product description
Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8028-1.
Reason for recall
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Distribution pattern
Nationwide in the US
Code information
Lot: KDC0124001A Exp 09/30/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0197-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026